BILL ANALYSIS                                                                                                                                                                                                    



                                                                  AB 1858
                                                                  Page  1


          ASSEMBLY THIRD READING
          AB 1858 (Blumenfield)
          As Amended April 13, 2010
          Majority vote 

           HEALTH              11-5        APPROPRIATIONS      12-5        
           
           ----------------------------------------------------------------- 
          |Ayes:|Monning, Ammiano, Carter, |Ayes:|Fuentes, Ammiano,         |
          |     |Bradford, De Leon, Eng,   |     |Bradford,                 |
          |     |Hayashi, Hernandez,       |     |Charles Calderon, Coto,   |
          |     |Jones, Bonnie Lowenthal,  |     |Davis,                    |
          |     |V. Manuel Perez           |     |De Leon, Hall, Skinner,   |
          |     |                          |     |Solorio, Torlakson,       |
          |     |                          |     |Torrico                   |
          |-----+--------------------------+-----+--------------------------|
          |Nays:|Fletcher, Emmerson,       |Nays:|Conway, Harkey, Miller,   |
          |     |Gaines, Smyth, Audra      |     |Nielsen, Norby            |
          |     |Strickland                |     |                          |
          |     |                          |     |                          |
           ----------------------------------------------------------------- 
           SUMMARY  :  Permits the Department of Public Health (DPH) to  
          authorize clinics or other entities to provide hypodermic needle  
          and syringe exchange services in any location where DPH  
          determines that the conditions exist for the rapid spread of  
          HIV, viral hepatitis, or any other potentially deadly or  
          disabling infections that are spread through the sharing of used  
          hypodermic needles and syringes.  Specifically,  this bill  :  

          1)Permits DPH to authorize clinics or other entities to provide  
            hypodermic needle and syringe exchange services in any  
            location where DPH determines that the conditions exist for  
            the rapid spread of HIV, viral hepatitis, or any other  
            potentially deadly or disabling infections that are spread  
            through the sharing of used hypodermic needles and syringes.  

          2)Requires DPH to establish and maintain on its Web site the  
            address and contact information of programs operating a needle  
            exchange project (NEP) pursuant to this bill. 

          3)Requires DPH to authorize NEPs under this bill as recommended  
            by the US Public Health Service, subject to the availability  
            of funding, as part of a network of comprehensive services,  
            including treatment services, as specified.








                                                                  AB 1858
                                                                  Page  2



          4)Prohibits staff and volunteers participating in a  
            DPH-authorized NEP from being subject to criminal prosecution  
            for any law related to the possession, furnishing, or transfer  
            of hypodermic needles for syringes during the participation in  
            an exchange project.  

          5)Requires DPH to provide local health officers (LHOs) biennial  
            status reports, as specified, based on reports to DPH from  
            service providers operating DPH-authorized NEPs within a LHO's  
            jurisdiction.  Requires LHOs with county- and city-authorized  
            NEPs to report on the program's status biennially (rather than  
            annually, as required by existing law).

           FISCAL EFFECT  :  According to the Assembly Appropriations  
          Committee:

          1)Annual General Fund costs to the DPH of  $30,000 to $40,000 in  
            2011 through 2013 to establish  regulations and comply with  
            other requirements of this bill, including hosting information  
            about projects on the internet and an expansion of reporting  
            related to local health jurisdictions. 

          2)Ongoing, likely absorbable costs for DPH to continue oversight  
            of needle exchange projects after 2013.

          3)Unknown, potentially significant savings to the extent this  
            bill reduces medical costs associated with infectious diseases  
            such as HIV and hepatitis.

           COMMENTS  :  According to the author, there are not nearly enough  
          programs providing syringe exchange services to meet the needs  
          of injection drug users who need sterile syringes in order to  
          avoid transmission of HIV and viral hepatitis.  The author also  
          states that there are significant statutory barriers to  
          establishing and maintaining syringe exchange programs, which  
          this bill seeks to ameliorate.  The requirement of a local  
          authorization vote has resulted in unequal access to  
          preventative health services.  This bill will allow DPH to  
          authorize health centers and other local entities to offer  
          syringe exchange services in any location where DPH determines  
          that the conditions exist for the rapid spread of HIV, viral  
          hepatitis, or any other potentially deadly or disabling  
          infections that are spread thorough the sharing of used  








                                                                  AB 1858
                                                                  Page  3


          syringes.  These deadly and costly infections in jurisdictions  
          without syringe exchange services are a state General Fund  
          problem, as well as a preventable personal and public health  
          tragedy.  The indigent ill are dependent on state funded medical  
          and prescription services.  The author contends that physicians  
          report that it is extremely common to tell a patient who has  
          been clean and sober for many years that they were infected with  
          hepatitis or HIV due to syringe sharing in their past, and then  
          begin the process of enrolling the patient in Medi-Cal and other  
          state supported health services.

          Injection drug use (IDU) is the second leading cause of HIV  
          transmission and the leading cause of the hepatitis C virus  
          (HCV) in California.  According to DPH's Office of AIDS, in 2009  
          IDU was associated with 19% of the 190,000 reported HIV/AIDS  
          cases, and it is estimated that approximately 750 new HIV  
          infections may be attributed to IDU each year.  The link between  
          IDU and HIV transmission is particularly strong for women and  
          minorities.  It is also estimated that at least 60% of prevalent  
          cases of HCV infection are associated with IDU.  In 2008, 36  
          acute HCV infections and 69,519 unique chronic HCV cases were  
          reported in California, and HCV-related deaths in the state more  
          than doubled from 503 in 1995 to 1,195 in 2004.  Public health  
          experts, including the federal Centers for Disease Control and  
          Prevention (CDC), have identified access to sterile syringes as  
          one component of a comprehensive HIV prevention strategy  
          designed to reduce HIV transmission among injection drug users.  

           According to the CDC, the first organized NEPs in the U.S. were  
          established in the late 1980s in Tacoma, Washington; Portland,  
          Oregon; San Francisco; and, New York City.  As of November 2007,  
          a total of 185 NEPs were operating in 36 states, the District of  
          Columbia, and Puerto Rico.  According to DPH, as of January  
          2010, 19 California counties and four cities have authorized  
          NEPs.  In addition to exchanging syringes, many NEPs provide a  
          range of related prevention and care services that are vital to  
          helping injection drug users reduce their risks of acquiring and  
          transmitting blood-borne viruses, as well as maintain and  
          improve their overall health.  These services include: HIV/AIDS  
          education and counseling; condom distribution to prevent sexual  
          transmission of HIV and other sexually transmitted diseases;  
          referrals to substance abuse treatment and other medical and  
          social services; distribution of alcohol swabs to help prevent  
          abscesses and other bacterial infections; on-site HIV testing  








                                                                  AB 1858
                                                                  Page  4


          and counseling and crisis intervention; screening for  
          tuberculosis, hepatitis B and C; and, primary medical services.   
          NEPs operate in a variety of settings, including storefronts,  
          vans, sidewalk tables, and health clinics.  They vary in their  
          hours of operation, with some open for two-hour street-based  
          sessions several times a week, and others are open continuously.  

           
           A January 2009 review of the effectiveness of syringe exchange  
          sponsored by the Robert Wood Johnson Foundation's Substance  
          Abuse Policy Research Program found that syringe exchanges are  
          cost-effective, help reduce HIV risk behavior and transmission,  
          can promote entry into drug treatment, and do not encourage  
          illegal drug use or other crime or increase the community burden  
          of discarded syringes.  

          Supporters of this bill write that over 200 studies from the  
          United States and abroad concur that improved syringe access  
          reduces the rate of HIV transmission, without increasing rates  
          of drug use, drug injection or crime.  Supporters further state  
          that NEPs reduce the number of syringes found in community  
          settings and link people to treatment and other services.  The  
          supporters assert that science shows overwhelmingly that NEPs  
          save lives without increasing drug use or crime, and that  
          preventing new infections is sound fiscal policy. 

          Opponents write that each community should retain sovereignty  
          concerning these important matters as there have been too many  
          instances of needle users dumping needles in the shelves of  
          stores and in parking lots adjacent to stores, and one instance  
          where a needle user, caught for shoplifting, threatened to stick  
          the store manager with a needle.
           

          Analysis Prepared by  :    Melanie Moreno / HEALTH / (916)  
          319-2097 


                                                                FN: 0004257